{"title":"Underreporting of adverse events to health authorities by healthcare professionals: a red flag-raising descriptive study.","authors":"Maude Lavallée, Sonia Corbin, Pallavi Pradhan, Laura Blonde Guefack, Magalie Thibault, Julie Méthot, Anick Bérard, Marie-Eve Piché, Fernanda Raphael Escobar Gimenes, Rosalie Darveau, Isabelle Cloutier, Jacinthe Leclerc","doi":"10.1093/intqhc/mzae109","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>An adverse event (AE) is any undesirable medical manifestation in an individual who has received pharmacological treatment. To be considered serious (SAE), it needs to meet minimally one of the severity criteria by Health Canada. The most recent data (2006) suggested that AEs were underreported (<6%) to health authorities. In Canada, since the implementation of Vanessa's Law (2019), hospitals are required to report SAEs, however this law remains relatively unknown.. The objectives of the study were: 1) to document the incidence of any adverse event (AE) and serious adverse event (SAE) over time in a \"real\" clinical context, 2) to quantify SAEs reported to Health Canada, and 3) to assess whether Vanessa's Law has led to an increase in mandatory reporting to Health Canada.</p><p><strong>Method: </strong>We carried out a descriptive retrospective study at the Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, including 500 patients hospitalized between 2018/01/01 and 2021/12/31 and randomized into 4 cohorts (125 patients/year). Descriptive and comparative analyses were performed.</p><p><strong>Results: </strong>The characteristics of the cohorts were: 43.6% women; median age: 69 years [min-max: 21-96 years], number of comorbidities: 4 [1-12]. During their hospitalization, patients consumed 18 different drug products [2-56] and the median of observed SAEs/patients was 0 [0-10] (total: 302). The overall percentage of SAEs reported to Health Canada was 0%, before and following the implementation of Vanessa's Law.</p><p><strong>Conclusion: </strong>According to 500 electronic medical records, SAEs were underreported to Health Canada, even after the implementation of Vanessa's law.</p>","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal for Quality in Health Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/intqhc/mzae109","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: An adverse event (AE) is any undesirable medical manifestation in an individual who has received pharmacological treatment. To be considered serious (SAE), it needs to meet minimally one of the severity criteria by Health Canada. The most recent data (2006) suggested that AEs were underreported (<6%) to health authorities. In Canada, since the implementation of Vanessa's Law (2019), hospitals are required to report SAEs, however this law remains relatively unknown.. The objectives of the study were: 1) to document the incidence of any adverse event (AE) and serious adverse event (SAE) over time in a "real" clinical context, 2) to quantify SAEs reported to Health Canada, and 3) to assess whether Vanessa's Law has led to an increase in mandatory reporting to Health Canada.
Method: We carried out a descriptive retrospective study at the Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, including 500 patients hospitalized between 2018/01/01 and 2021/12/31 and randomized into 4 cohorts (125 patients/year). Descriptive and comparative analyses were performed.
Results: The characteristics of the cohorts were: 43.6% women; median age: 69 years [min-max: 21-96 years], number of comorbidities: 4 [1-12]. During their hospitalization, patients consumed 18 different drug products [2-56] and the median of observed SAEs/patients was 0 [0-10] (total: 302). The overall percentage of SAEs reported to Health Canada was 0%, before and following the implementation of Vanessa's Law.
Conclusion: According to 500 electronic medical records, SAEs were underreported to Health Canada, even after the implementation of Vanessa's law.
期刊介绍:
The International Journal for Quality in Health Care makes activities and research related to quality and safety in health care available to a worldwide readership. The Journal publishes papers in all disciplines related to the quality and safety of health care, including health services research, health care evaluation, technology assessment, health economics, utilization review, cost containment, and nursing care research, as well as clinical research related to quality of care.
This peer-reviewed journal is truly interdisciplinary and includes contributions from representatives of all health professions such as doctors, nurses, quality assurance professionals, managers, politicians, social workers, and therapists, as well as researchers from health-related backgrounds.